Related Experiment Video
Updated: Jun 28, 2025
Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
Published on: May 2, 2011
[Position statement of the Spanish Society of Nephrology on the SARS-CoV-2 vaccines]
Emilio Sánchez-Álvarez1,2, Borja Quiroga3,2, Patricia de Sequera4,2
1Servicio de Nefrología, Hospital Universitario de Cabueñes, Gijón, España.
Abstract:
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide over the last year causing more than one million deaths. Several treatments have tried to modify the natural history of the coronavirus disease 2019 (COVID-19) but only corticosteroids have demonstrated to be effective in moderate or severe affectation. In that situation, the development of vaccines for preventing the SARS-CoV-2 infection has focused the attention of the scientific community. At present, available messenger RNA-based technology vaccines have received the approval of local and international sanitary authorities. In this position statement, the Spanish Society of Nephrology wants to state that patients with chronic kidney disease and healthcare workers are at high-risk for contagion and complications of COVID-19 so they must have priority in the vaccine administration.
Insights
Patients with chronic kidney disease and healthcare workers are at high risk for COVID-19 complications. The Spanish Society of Nephrology recommends prioritizing these groups for messenger RNA vaccine administration.
Area of Science:
- Nephrology
- Infectious Diseases
- Vaccinology
Context:
- The global spread of SARS-CoV-2 has led to significant mortality.
- Corticosteroids are effective for moderate to severe COVID-19.
- Vaccine development is a primary focus for SARS-CoV-2 prevention.
Purpose:
- To outline the Spanish Society of Nephrology's position on COVID-19 vaccination.
- To identify high-risk populations for SARS-CoV-2 infection and complications.
Summary:
- Messenger RNA (mRNA) vaccines are approved and available.
- Patients with chronic kidney disease (CKD) face elevated risks from SARS-CoV-2.
- Healthcare workers are also identified as a high-risk group.
Impact:
- Recommends prioritizing CKD patients and healthcare workers for vaccination.
- Highlights the critical role of vaccination in mitigating COVID-19 impact on vulnerable populations.
- Advocates for equitable vaccine distribution strategies based on risk assessment.
More Related Videos
Related Concept Videos
01:51Vaccinations
01:11Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
01:06Renal Drug Clearance: Overview
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
01:25Antihypertensive Drugs: Direct Renin Inhibitors
01:15Renal Drug Excretion: Overview
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules...